Your Article Summary
See Latest ArticlesComparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma
Pathology International, 06/26/09
Imai H et al. - CNS DLBCL patients did not differ in age, sex, or immunophenotype, including CD5 positivity, from IVLBCL patients, but were significantly less likely to have poor prognostic parameters than IVLBCL patients: the international prognostic index score was low or low-intermediate in 86% of CNS DLBCL patients and high or high-intermediate in 98% of IVLBCL patients. Notably, despite this difference, their survival curves almost overlapped.
Related Articles
Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy
International Journal of Hematology, 12/01/09
Relevance Score: 94%
Anaplastic large cell lymphoma in a patient with rheumatoid arthritis
Rheumatology International, 11/10/09
Relevance Score: 91%
Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
British Journal of Haematology, 11/04/09
Relevance Score: 91%
Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma
Blood, 11/02/09
Relevance Score: 91%
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations
British Journal of Haematology, 11/23/09
Relevance Score: 90%
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)
Cancer, 12/16/09
Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway
Carcinogenesis, 12/16/09
Genomic profiling of Richters syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas
Hematological Oncology, 12/16/09
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeTEST
Journal of Neuro-Oncology, 12/17/09
Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients
International Journal of Cancer, 12/16/09
Brain metastases in HER2-positive breast cancer: The evolving role of lapatinib
Critical Reviews in Oncology/Hematology, 12/15/09